General Provisions - The management system for the shares held by the board of directors and senior management of Xianle Health Technology Co., Ltd. is established to regulate shareholding and changes in accordance with relevant laws and regulations [1][2] - This system applies to the board of directors, senior management, and other specified individuals or organizations holding and trading the company's stocks and derivatives [1] Holding and Reporting Requirements - Directors and senior management must report their shareholdings and any changes to the Shenzhen Stock Exchange (SZSE) in a timely manner, ensuring the information is true, accurate, timely, and complete [2][3] - Personal and family identity information must be reported to SZSE within specified timeframes, including when new directors are appointed or when there are changes in personal information [2][3] Restrictions on Trading Company Shares - Directors and senior management must notify the board secretary in writing of their trading plans before buying or selling company shares, and the secretary must verify compliance with laws and regulations [3][4] - The annual transferable share limit for directors and senior management is calculated at 25% of the shares held as of the last trading day of the previous year [4][5] Lock-up and Transfer Conditions - Shares held by directors and senior management are subject to lock-up conditions, and the release of these conditions must be applied for through the appropriate channels [5][6] - Directors and senior management are prohibited from transferring shares within six months of leaving their positions and must adhere to specific transfer limits during their tenure [5][6] Information Disclosure - Any reduction in shareholding must be reported to SZSE 15 trading days prior to the first sale, and updates must be provided if significant company events occur during the reduction period [8][9] - The board secretary is responsible for managing the identity and shareholding data of directors and senior management, ensuring compliance with reporting requirements [9][10] Final Provisions - The system is subject to modification and will take effect upon approval by the board of directors [10]
仙乐健康: 董事、高级管理人员所持公司股份及其变动管理制度(2025年7月)